The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.162%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 306.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Deputy Chair and Chair-elect

30 Mar 2020 07:00

RNS Number : 9553H
Synthomer PLC
30 March 2020
 

Synthomer plc

30th March 2020

 

Synthomer plc ('Synthomer')

 

Caroline Johnstone appointed Deputy Chair and Chair-elect of Synthomer

 

The Board of Directors ('the Board') of Synthomer ('the Company') announces today that Neil Johnson will step down as Chairman of the Company by the end of the year. Neil has served as Chairman for eight years since his appointment to the Board in September 2011 as a non-executive director. At the 2020 AGM Neil will seek re-election as a Director in order to serve as Chairman until the end of the year.

 

Following an external and internal process, the Board is pleased to announce that Caroline Johnstone will be appointed Chair upon Neil's departure. She will take up the position of Deputy Chair with immediate effect. Caroline joined the Board of Synthomer as a non-executive director in 2015 and is currently Chair of the Audit Committee and a member of the Nomination and Remuneration Committees.

 

Caroline has nearly 40 years' experience of working with large global organisations on turnaround, culture change, delivering value from mergers and acquisitions and cost optimisation programmes. She was a partner and sat on the board of the Assurance practice of PricewaterhouseCoopers (PwC) with responsibility for all people matters. Caroline is a chartered accountant and a member of the Institute of Chartered Accountants of Scotland. She is a non-executive director of Spirax Sarco Engineering plc and two private companies and by the end of 2020 intends to have two non-executive roles in addition to Synthomer plc.

 

Neil Johnson, Chairman of Synthomer, commented:

 

"It has been a pleasure serving on the Board of Synthomer since 2011, during which time we have made significant progress in establishing the Company as a leading, global, differentiated chemicals business. Despite the challenges of the current economic environment, the recent completion of a material capital investment programme and the benefits that will come from the acquisition of OMNOVA give me confidence that the Company is well-placed for the future. I am delighted that I will be succeeded as Chair by Caroline Johnstone, who has made a significant contribution to the Company during her time on the Board, and I look forward to continuing to serve Synthomer until I hand over by the end of the year.." 

 

Enquiries:

 

Synthomer plc

Tel: + 44 7764 859147

Calum MacLean, Chief Executive Officer

 

Stephen Bennett, Chief Financial Officer

 

Tim Hughes, President, Corporate Development

 

 

 

Teneo

Tel: + 44 7703 330269

Charles Armitstead / Matt Denham

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDXLXDDGGC
Date   Source Headline
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.